A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2genes

BackgroundDetection of mutations by DNA sequencing can be facilitated by scanning methods to identify amplicons which may have mutations. Current scanning methods used for the detection of germline sequence variants are laborious as they require post-PCR manipulation. High resolution melting (HRM) is a cost-effective rapid screening strategy, which readily detects heterozygous variants by melting curve analysis of PCR products. It is well suited to screening genes such as BRCA1 and BRCA2 as germline pathogenic mutations in these genes are always heterozygous.MethodsAssays for the analysis of all coding regions and intron-exon boundaries of BRCA1 and BRCA2 were designed, and optimised. A final set of 94 assays which ran under identical amplification conditions were chosen for BRCA1 (36) and BRCA2 (58). Significant attention was placed on primer design to enable reproducible detection of mutations within the amplicon while minimising unnecessary detection of polymorphisms. Deoxyinosine residues were incorporated into primers that overlay intronic polymorphisms. Multiple 384 well plates were used to facilitate high throughput.Results169 BRCA1 and 239 BRCA2 known sequence variants were used to test the amplicons. We also performed an extensive blinded validation of the protocol with 384 separate patient DNAs. All heterozygous variants were detected with the optimised assays.ConclusionsThis is the first HRM approach to screen the entire coding region of the BRCA1 and BRCA2 genes using one set of reaction conditions in a multi plate 384 well format using specifically designed primers. The parallel screening of a relatively large number of samples enables better detection of sequence variants. HRM has the advantages of decreasing the necessary sequencing by more than 90%. This markedly reduced cost of sequencing will result in BRCA1 and BRCA2 mutation testing becoming accessible to individuals who currently do not undergo mutation testing because of the significant costs involved.

[1]  K. Voelkerding,et al.  Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. , 2007, Clinical chemistry.

[2]  Zhiyuan Shen,et al.  Direct sequencing with highly degenerate and inosine-containing primers. , 2003, Methods in molecular biology.

[3]  W. Rubinstein.  Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics , 2007, Familial Cancer.

[4]  Robert Palais,et al.  High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. , 2005, Clinical chemistry.

[5]  Carl T Wittwer,et al.  High-resolution DNA melting analysis for simple and efficient molecular diagnostics. , 2007, Pharmacogenomics.

[6]  J. Satagopan,et al.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.

[7]  R. Lidereau,et al.  A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis. , 2010, Genetic testing and molecular biomarkers.

[8]  V. Timmerman,et al.  Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. , 2007, Clinical chemistry.

[9]  D. Glavač,et al.  DHPLC screening of cystic fibrosis gene mutations , 2002, Human mutation.

[10]  C. Wittwer,et al.  Scanning the cystic fibrosis transmembrane conductance regulator gene using high-resolution DNA melting analysis. , 2007, Clinical chemistry.

[11]  J. Weitzel,et al.  A cautionary note: false homozygosity for BRCA2 6174delT mutation resulting from a single nucleotide polymorphism masking the wt allele , 2002, European Journal of Human Genetics.

[12]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[13]  W. Foulkes,et al.  BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.

[14]  B. Ponder,et al.  Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing , 2001, Genes, chromosomes & cancer.

[15]  S. Fox,et al.  Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis , 2008, BMC Cancer.

[16]  Anne De Paepe,et al.  Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms. , 2008, Clinical chemistry.

[17]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[18]  David M. Thomas,et al.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer , 2006, BMC Cancer.

[19]  Carl T Wittwer,et al.  High-resolution DNA melting analysis in clinical research and diagnostics , 2010, Expert review of molecular diagnostics.

[20]  Thomas Mikeska,et al.  Validation of a primer optimisation matrix to improve the performance of reverse transcription – quantitative real-time PCR assays , 2009, BMC Research Notes.

[21]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[22]  C. Weilke,et al.  30 Mutation Scanning Using High Resolution Melting or dHPLC : a Performance Comparison Study , 2009 .

[23]  E. Bakker,et al.  Diagnostic guidelines for high‐resolution melting curve (HRM) analysis: An interlaboratory validation of BRCA1 mutation scanning using the 96‐well LightScanner™ , 2009, Human mutation.

[24]  Gregory J Tsongalis,et al.  BRCA1 and BRCA2 mutation screening using SmartCycler II high-resolution melt curve analysis. , 2006, Archives of pathology & laboratory medicine.

[25]  Anna Maria Rossi,et al.  Application of High-Resolution Melting to Large-Scale, High-Throughput SNP Genotyping , 2010, Journal of biomolecular screening.

[26]  K. Claes,et al.  Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. , 2009, The Journal of molecular diagnostics : JMD.

[27]  S. Fox,et al.  High resolution melting for mutation scanning of TP53 exons 5–8 , 2007, BMC Cancer.

[28]  P. Oefner,et al.  Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. , 1999, Genomics.

[29]  Carl T Wittwer,et al.  Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. , 2004, Clinical chemistry.

[30]  P. Vorkas,et al.  Mutation scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis. , 2010, Clinical biochemistry.

[31]  Carl T Wittwer,et al.  High-resolution genotyping by amplicon melting analysis using LCGreen. , 2003, Clinical chemistry.

[32]  E. Solomon,et al.  The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. , 1996, Oncogene.

[33]  E. Lyon,et al.  A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. , 2005, American journal of clinical pathology.

[34]  E. Lyon,et al.  A Comparison of High-Resolution Melting Analysis With Denaturing High-Performance Liquid Chromatography for Mutation Scanning , 2005 .

[35]  P. Bolufer,et al.  High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations , 2009, Breast Cancer Research and Treatment.